Cargando…
Female Patient with Two Simultaneous Giants Facial Basal Cell Carcinomas Demonstrates a Positive Response to Vismodegib as a Monotherapy
Basal cell carcinoma (BCC) is the most frequent histological type of cancer in the world and accounts for approximately 80% of all skin cancers. In the majority of cases, they are slow-growing, low metastatic potential tumors, easy to cure by surgical or nonsurgical procedures. Giant BCC (GBCC) is a...
Autores principales: | Theotokoglou, Sofia, Sgouros, Dimitrios, Theodoropoulos, Konstantinos, Syrmali, Anna, Polyderas, George, Katoulis, Alexander C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906300/ https://www.ncbi.nlm.nih.gov/pubmed/35283500 http://dx.doi.org/10.4103/ijd.ijd_37_21 |
Ejemplares similares
-
Real World Data on Efficacy and Safety of Vismodegib in Greek Patients with Advanced, Multiple and Metastatic Basal Cell Carcinoma
por: Sgouros, Dimitrios, et al.
Publicado: (2022) -
Novel Insights for Patients with Multiple Basal Cell Carcinomas and Tumors at High-Risk for Recurrence: Risk Factors, Clinical Morphology, and Dermatoscopy
por: Sgouros, Dimitrios, et al.
Publicado: (2021) -
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients’ Illness Perceptions
por: Sgouros, Dimitrios, et al.
Publicado: (2022) -
Dermoscopy as a Tool in Differentiating Cutaneous Squamous Cell Carcinoma From Its Variants
por: Sgouros, Dimitrios, et al.
Publicado: (2021) -
Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)